Subscribe To
Gsk shares up 3.4% after zantac settlement
Shares in GSK PLC (LSE:GSK, NYSE:GSK) rose by 3.4% following the announcement of a confidential settlement reached by the UK ...
June 23, 2023, 3:18 am
Matrix capital infuses $108 million into zentalis toward promising cancer therapeutics
Shares of Zentalis pharmaceuticals Inc (US:ZNTL) are cooling off a bit Thursday after yesterday's 4% ri...
June 22, 2023, 10:21 pm
Intercept receives complete response letter from fda for obeticholic acid as a treatment for pre-cirrhotic fibrosis due to nash
Company to discontinue all NASH-related investment and restructure the Company’s operations to strengthen its focus on rare and serious liver diseas...
June 22, 2023, 9:45 pm
Disc medicine announces closing of public offering of common stock and pre-funded warrants including full exercise of underwriters’ option to purchase additional shares
WATERTOWN, Mass., June 22, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage bio...
June 22, 2023, 8:15 pm
Atossa therapeutics announces sponsorship of are you dense musicfest 2023
SEATTLE, June 22, 2023 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biophar...
June 22, 2023, 8:15 pm
Altis labs closes $7.9 million cad to evaluate cancer treatments using ai
Toronto-based Altis Labs, which helps biopharmaceutical companies analyze medical imaging and expedite ...
June 22, 2023, 6:14 pm
Us fda declines to approve intercept's fatty liver disease drug
The U.S. Food and Drug Administration on Thursday declined to grant accelerated approval for Intercept pharmac...
June 22, 2023, 6:00 pm
Marinus: transforming the seizure market with ganaxolone (rating upgrade)
Marinus pharmaceuticals has pivoted from postpartum depression to focus on seizure disorders, leading t...
June 22, 2023, 5:55 pm
pharmaceutical m&a thriving as global dealmaking struggles to stay healthy
The M&A market is under the weather. Nearly halfway into 2023, global transaction values total $1.1 trillion, $900 billion less than this point last y...
June 22, 2023, 2:38 pm
Are medical stocks lagging ani pharmaceuticals (anip) this year?
Here is how ANI pharmaceuticals (ANIP) and Cardiol Therapeutics Inc. (CRDL) have performed compared to ...
June 22, 2023, 11:06 am
I'm buying these 3 resilient stocks during a bear market
Pfizer and Bristol Myers Squibb are pharmaceutical giants that are priced just right. NNN is a real est...
June 22, 2023, 10:23 am
Is the options market predicting a spike in catalyst pharmaceuticals (cprx) stock?
Investors need to pay close attention to Catalyst pharmaceuticals (CPRX) stock based on the movements i...
June 22, 2023, 10:21 am
Reviva pharmaceuticals announces 80% global enrollment update for pivotal phase 3 recover study evaluating brilaroxazine for schizophrenia
– Enrollment ongoing at multiple sites in the US, Europe, and Asia – – Multifaceted activity of serotonin-dopamine stabilizer brilaroxazine supp...
June 22, 2023, 10:00 am
Paxmedia hires shareintel to look into recent stock weakness, after a 45% plunge amid an 8-day losing streak
Shares of PaxMedia Inc. PXMD, -11.91% bounced 2.0% in premarket trading Thursday, after the biopharmaceutical<...
June 22, 2023, 8:52 am
Will johnson & johnson be a trillion-dollar stock by 2038?
The global pharmaceutical industry keeps growing. J&J looks positioned to deliver growth for the long h...
June 22, 2023, 8:10 am
Madrigal pharmaceuticals presents phase 3 maestro-nash data during the opening general session of the easl congress™
First scientific presentation of detailed MAESTRO-NASH results confirms achievement of primary endpoints across multiple patient subgroups Noninvasive...
June 22, 2023, 7:30 am
3 biotech stocks to buy as companies ink major deals
With patent expirations around the corner, some of the biggest pharmaceutical and biotech companies wil...
June 22, 2023, 6:40 am
Elite pharmaceuticals, inc. to host conference call to provide corporate update and discuss fiscal year 2023 financial results on june 30, 2023
Financials for Fiscal Year 2023 Ended March 31, 2023 will be released on June 29, 2023 NORTHVALE, NJ / ACCESSWIRE / June 22, 2023 / Elite ...
June 22, 2023, 6:00 am
Ligand pharmaceuticals: the new ligand is looking good
The article discusses the recent developments and transformation of Ligand pharmaceuticals. It follows ...
June 22, 2023, 3:29 am
Alert: the m&a class action firm continues investigating the merger – prtk, nex, synh, aaic
NEW YORK, June 21, 2023 (GLOBE NEWSWIRE) — Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the �...
June 21, 2023, 11:40 pm